MALVERN, PA, USA (Press Release) - June 1, 2009
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
- Notice
Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting
Your session will expire in 8 hours requiring you to log in each day to view content.